AE2-66415-30504
2 vaccinations
1 coded response
12 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 330 / FL
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Moderna
-
2021-04-13
Dose 2 — Moderna
-
2021-04-16
Registered in v-safe
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-27
- 2021-05-06
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Office visit, Ovarian disorder, Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Symptoms: Delayed ovalation, disrupting cycle. Early miscarriage. Additionallg persistent rash on lower back since 2nd vaccine · Healthcare visit (other): Office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-19
-
2021-07-19
Call successfulParticipant prefers to complete VAERS report online
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Moderna | |
| 2 | 2021-04-13 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-13 | Successful 2021-07-19 |
Participant prefers to complete VAERS report online |
Free text
Release 9 — 3 months, dose 2
Symptoms: Delayed ovalation, disrupting cycle. Early miscarriage. Additionallg persistent rash on lower back since 2nd vaccine
Healthcare visit (other): Office visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Ovarian disorder | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release